This recording with Alex Zhavoronkov is from our Longevity Biotechnology seminar series, hosted online on June 18th, 2026. View the talk along with the visual presentation on our Youtube channel.
Alex Zhavoronkov is the founder and CEO of Insilico Medicine, a clinical-stage biotech building AI platforms for drug discovery and aging research. In this talk, Alex breaks down what a genuinely scalable AI-first biotech looks like from the inside: how to measure scientific productivity with rigorous benchmarks, how to balance internal program progression with licensing, and how to build an AI platform that compounds value with every drug it runs. Drawing on his experience at Insilico, he makes the case for a new model of biotech that can grow, learn, and sustain itself over time.
If you want to join future seminars live, the schedule is at foresight.org and in our Luma calendar.
","author_name":"Foresight Institute"}